. 2018 May 14;14:909–928. doi: 10.2147/TCRM.S161326

Table 1.

Clinical information from the eligible trials in the meta-analysis

Included studies	Country	Type of stroke: acute/chronic	Patients: control/experimental	Age (years)		Parameter types
Included studies	Country	Type of stroke: acute/chronic	Patients: control/experimental	Control	Experimental	Parameter types
Bang et al23	Korea	Acute	25/5	ND	ND	BI
Bhasin et al24	India	Chronic	20/20	45.2±11.8	45.1±12.1	FMA, BI
Bhasin et al25	India	Chronic	6/6	46.5±6.3	42±9.3	FMA, BI, AE
Cai et al26	China	Chronic	21/21	62.7±6.9	61.4±6.7	FMA, FIM, BI
Cheng et al27	China	Acute	18/18	68.1±2.5	69.1±1.2	FIM, BI
Chen et al28	China	ND	43/43	ND	ND	FMA, FIM
Chen et al29	China	ND	30/30	57.4±9.6	49.3±20.8	NIHSS
Deng et al30	China	ND	15/15	ND	ND	NIHSS
Feng et al31	China	ND	50/50	60.2±11.8	61.4±11.3	NIHSS
He32	China	ND	18/20	54.3±8.7	56.4±7.9	NIHSS, BI
Hu et al33	China	ND	60/60	59.2±13.8	60.8±15.2	FMA, FIM
Ji et al34	China	ND	60/60	ND	ND	FMA, BI
Lee et al35	Korea	Acute	36/16	64.9±14.5	64.0±11.6	AE
Liu et al36	China	ND	29/29	56.9±4.4	55.3±3.6	NIHSS, FMA, BI
Meng et al37	China	ND	30/30	52.9±8.3	52.7±7.9	FMA, FIM
Shen38	China	Acute	16/16	ND	52±10.4	FIM
Song et al39	China	ND	28/28	65.4	63.2	NIHSS
Sun et al40	China	Acute	22/20	58.9±7.4	57.8±8.9	NIHSS, BI
Sun et al41	China	ND	15/20	30.9±16.9	29.5±9.4	FMA
Tsang et al42	Hong Kong	Chronic	4/5	51.5	53.4	FIM, BI, AE
Wang et al43	China	ND	60/60	ND	ND	FIM
Xie et al44	China	ND	30/30	53.7±6.1	51.4±7.2	NIHSS, BI
Zhao et al45	China	ND	18/23	53.3±18.9	50.2±20.0	NIHSS

Note: Data are presented as mean±SD or median.

Abbreviations: ND, nondetermined; NIHSS, National Institutes of Health Stroke Scale; BI, Barthel index; FMA, Fugl-Meyer Assessment; FIM, Functional Independence Measure; AE, adverse event.